[CHRS] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- 12.11%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 326,551 475,824 356,071 1,556 1,556 190,106 30,041 48.78%
PBT -287,100 135,707 92,775 -209,409 -238,286 -127,788 -223,938 4.22%
Tax 19,222 3,463 2,942 4,691 9,440 656 -7,352 -
NP -306,322 132,244 89,833 -209,339 -238,170 -127,337 -223,260 5.40%
Tax Rate - -2.55% -3.17% - - - - -
Total Cost 632,873 343,580 266,238 210,895 239,726 317,443 253,301 16.47%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -93.81 27.79 25.23 -13,453.66 -15,306.56 -66.98 -743.18 -29.15%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -4.06 1.85 1.29 -3.22 -4.48 -3.04 -6.01 -6.32%
EPS Diluted -4.06 1.62 1.23 -3.22 -4.48 -3.04 -6.01 -6.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.